Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.290
+0.050 (1.18%)
At close: Feb 6, 2026, 4:00 PM EST
4.280
-0.010 (-0.23%)
After-hours: Feb 6, 2026, 7:13 PM EST
Precigen Employees
Precigen had 143 employees as of December 31, 2024. The number of employees decreased by 59 or -29.21% compared to the previous year.
Employees
143
Change (1Y)
-59
Growth (1Y)
-29.21%
Revenue / Employee
$44,119
Profits / Employee
-$2,978,084
Market Cap
1.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 143 | -59 | -29.21% | 143 | 0 |
| Dec 31, 2023 | 202 | -7 | -3.35% | 202 | 0 |
| Dec 31, 2022 | 209 | -302 | -59.10% | 209 | 0 |
| Dec 31, 2021 | 511 | 34 | 7.13% | 456 | 55 |
| Dec 31, 2020 | 477 | -380 | -44.34% | 423 | 54 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 493 |
| Agios Pharmaceuticals | 488 |
| uniQure | 209 |
| Celldex Therapeutics | 186 |
| Tango Therapeutics | 155 |
| Innoviva | 127 |
| Definium Therapeutics | 74 |
| Enliven Therapeutics | 65 |
PGEN News
- 17 days ago - New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis - PRNewsWire
- 22 days ago - Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 25 days ago - Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 weeks ago - Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Precigen Is Still A Buy After The Papzimeos Rally - Seeking Alpha
- 3 months ago - Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PRNewsWire
- 3 months ago - Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 - PRNewsWire